GSK receives positive CHMP opinion for REVOLADETM in thrombocytopenia associated with chronic hepatitis C infection
26 July 2013 | By GlaxoSmithKline
“A sustained virologic response is the goal for treatment of hepatitis C infection..."
List view / Grid view
News
Afatinib receives positive CHMP opinion for patients with EGFR mutation positive lung cancer in European Union
26 July 2013 | By Boehringer Ingelheim
"Boehringer Ingelheim welcomes the decision by the CHMP..."
Novartis first in class once-daily dual bronchodilator Ultibro® Breezhaler® (QVA149) gains positive CHMP opinion for the treatment of COPD
26 July 2013 | By Novartis
Novartis announced that the EMA's CHMP has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®...
Takeda receives positive CHMP opinion for three new type 2 diabetes therapies, VipidiaTM (alogliptin) and fixed-dose combinations VipdometTM (alogliptin-metformin) and IncresyncTM (alogliptin-pioglitazone)
26 July 2013 | By Virgo Health
“The number of people at risk from complications associated with type 2 diabetes continues to rise..."
US FDA acknowledges receipt of resubmission of the New Drug Application for investigational compound dapagliflozin for the treatment of type 2 diabetes
25 July 2013 | By AstraZeneca
The US FDA has acknowledged receipt of the NDA resubmission for investigational drug dapagliflozin for the treatment of adults with type 2 diabetes...
Abbott receives FDA clearance for FreeStyle Precision Pro Blood Glucose and β–Ketone Monitoring System™
25 July 2013 | By Abbott
Abbott has received U.S. FDA clearance for its FreeStyle Precision Pro Blood Glucose and β-Ketone Monitoring System™...
AstraZeneca and Bristol-Myers Squibb resubmit dapagliflozin New Drug Application for the treatment of type 2 diabetes in the U.S
25 July 2013 | By AstraZeneca
NDA for dapagliflozin resubmitted to FDA...
First patient receives innovative new treatment to tackle combined diabetes and obesity in NHS approved trial
25 July 2013 | By Sanofi
Combined diabetes and obesity, ‘diabesity’, is a serious health problem...
UK children remain unnecessarily at risk for life-threatening and disabling meningitis B disease
24 July 2013 | By Novartis
Following JCVI interim recommendation on Novartis Bexsero® vaccine...
Merck announces FDA acceptance of New Drug Application for Vorapaxar
24 July 2013 | By Merck
Merck announced that the NDA for vorapaxar, has been accepted for standard review...
Roche’s obinutuzumab (GA101) delayed disease progression longer than MabThera/Rituxan in people with one of the most common forms of blood cancer
24 July 2013 | By Roche
Results from the phase III CLL11 study...
Bristol-Myers Squibb partners with the Centers for Disease Control Foundation
23 July 2013 | By Bristol-Myers Squibb Company
Joint effort supports early disease identification to connect at-risk patients to necessary care...
SPS Pharma Services relocates to a new facility
23 July 2013 | By SOTAX AG
SPS Pharma Services, a worldwide leader for dissolution method development has moved to its new site in Orleans, France...
“Roche Continents” at the Salzburg Festival explores the common ground of creativity in art and science
22 July 2013 | By Roche
Roche invites 100 students from all over Europe to the Salzburg Festival...
The Apprentice’s Nick Hewer to host IChemE Awards
22 July 2013 | By IChemE
The Institution of Chemical Engineers has announced The Apprentice’s Nick Hewer to host IChemE Awards...
